Closed transaction

Laboratorios Eticos has sold a 50% equity stake to the Chemo Group

Advised by
Client
Counterparty
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Sub-sector
Other Healthcare
Market
Americas
Contact
martin.peters@alpax.com

Deal details

Laboratorios Eticos is a recognized pharmaceutical company in Paraguay. Founded in Argentina, Chemo has developed into a reknown international pharmaceutical company that is now headquartered in Spain. The transaction involves the acquisition by Chemo of a 50% Equity Stake in Laboratorios Eticos (Paraguay) so as to form a strategic joint-venture. Alpax acted as exclusive financial advisor to the Shareholders of Laboratorios Eticos.

Martin Peters FirmAlpax Martin joined Alpax after seven years at ING. View profile

Alpax latest deals

Sell-side advisory

Fabrilacteos (Helados Jotaerre) was sold to Estridsa (Helados Ginos).

Adviser
Alpax
Where
Bolivia
Year
2025
Sell-side advisory

La Industria Harinera sold a majority stake to Danec.

Adviser
Alpax
Where
Bolivia
Year
2025
Sell-side advisory

Vita Alimentos acquired Delcampo "La Holandesa".

Adviser
Alpax
Where
Bolivia
Year
2025
Sell-side advisory

Marangatú & Yacaré (Servant Family) was sold to Agropeco S.A.

Adviser
Alpax
Where
Bolivia
Year
2025

More by Alpax

More deals in Healthcare

Sell-side advisory

NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.

Where
Spain
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Switzerland
Year
2025

More Healthcare

More deals in Americas

Buy-side advisory

RMH Systems acquired Top Shelf Integrated Solutions.

Where
United States of America
Year
2026
Buy-side advisory

Road Safety Services acquired Iowa Plains Signing, Inc.

Where
United States of America
Year
2026
Sell-side advisory

Cedar Valley Corp. was acquired by Concrete Technologies, Inc.

Where
United States of America
Year
2026

More Americas

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

Contact us